136 related articles for article (PubMed ID: 9468536)
1. Transgenic approaches to define the functional role of dual site phospholamban phosphorylation.
Luo W; Chu G; Sato Y; Zhou Z; Kadambi VJ; Kranias EG
J Biol Chem; 1998 Feb; 273(8):4734-9. PubMed ID: 9468536
[TBL] [Abstract][Full Text] [Related]
2. Functional interplay between dual site phospholambam phosphorylation: insights from genetically altered mouse models.
Chu G; Kranias EG
Basic Res Cardiol; 2002; 97 Suppl 1():I43-8. PubMed ID: 12479233
[TBL] [Abstract][Full Text] [Related]
3. A single site (Ser16) phosphorylation in phospholamban is sufficient in mediating its maximal cardiac responses to beta -agonists.
Chu G; Lester JW; Young KB; Luo W; Zhai J; Kranias EG
J Biol Chem; 2000 Dec; 275(49):38938-43. PubMed ID: 10988285
[TBL] [Abstract][Full Text] [Related]
4. Pentameric assembly of phospholamban facilitates inhibition of cardiac function in vivo.
Chu G; Li L; Sato Y; Harrer JM; Kadambi VJ; Hoit BD; Bers DM; Kranias EG
J Biol Chem; 1998 Dec; 273(50):33674-80. PubMed ID: 9837953
[TBL] [Abstract][Full Text] [Related]
5. Ser16 prevails over Thr17 phospholamban phosphorylation in the beta-adrenergic regulation of cardiac relaxation.
Kuschel M; Karczewski P; Hempel P; Schlegel WP; Krause EG; Bartel S
Am J Physiol; 1999 May; 276(5):H1625-33. PubMed ID: 10330247
[TBL] [Abstract][Full Text] [Related]
6. Role of dual-site phospholamban phosphorylation in the stunned heart: insights from phospholamban site-specific mutants.
Said M; Vittone L; Mundina-Weilenmann C; Ferrero P; Kranias EG; Mattiazzi A
Am J Physiol Heart Circ Physiol; 2003 Sep; 285(3):H1198-205. PubMed ID: 12763747
[TBL] [Abstract][Full Text] [Related]
7. Chronic SR Ca2+-ATPase inhibition causes adaptive changes in cellular Ca2+ transport.
Brittsan AG; Ginsburg KS; Chu G; Yatani A; Wolska BM; Schmidt AG; Asahi M; MacLennan DH; Bers DM; Kranias EG
Circ Res; 2003 Apr; 92(7):769-76. PubMed ID: 12637367
[TBL] [Abstract][Full Text] [Related]
8. Monomeric phospholamban overexpression in transgenic mouse hearts.
Chu G; Dorn GW; Luo W; Harrer JM; Kadambi VJ; Walsh RA; Kranias EG
Circ Res; 1997 Oct; 81(4):485-92. PubMed ID: 9314829
[TBL] [Abstract][Full Text] [Related]
9. Immunodetection of phosphorylation sites gives new insights into the mechanisms underlying phospholamban phosphorylation in the intact heart.
Mundiña-Weilenmann C; Vittone L; Ortale M; de Cingolani GC; Mattiazzi A
J Biol Chem; 1996 Dec; 271(52):33561-7. PubMed ID: 8969222
[TBL] [Abstract][Full Text] [Related]
10. Targeted inhibition of sarcoplasmic reticulum CaMKII activity results in alterations of Ca2+ homeostasis and cardiac contractility.
Ji Y; Zhao W; Li B; Desantiago J; Picht E; Kaetzel MA; Schultz Jel J; Kranias EG; Bers DM; Dedman JR
Am J Physiol Heart Circ Physiol; 2006 Feb; 290(2):H599-606. PubMed ID: 16143658
[TBL] [Abstract][Full Text] [Related]
11. Ser16-, but not Thr17-phosphorylation of phospholamban influences frequency-dependent force generation in human myocardium.
Brixius K; Wollmer A; Bölck B; Mehlhorn U; Schwinger RH
Pflugers Arch; 2003 Nov; 447(2):150-7. PubMed ID: 14530977
[TBL] [Abstract][Full Text] [Related]
12. Cardiac-specific overexpression of a superinhibitory pentameric phospholamban mutant enhances inhibition of cardiac function in vivo.
Zhai J; Schmidt AG; Hoit BD; Kimura Y; MacLennan DH; Kranias EG
J Biol Chem; 2000 Apr; 275(14):10538-44. PubMed ID: 10744747
[TBL] [Abstract][Full Text] [Related]
13. Cardiac-specific overexpression of phospholamban alters calcium kinetics and resultant cardiomyocyte mechanics in transgenic mice.
Kadambi VJ; Ponniah S; Harrer JM; Hoit BD; Dorn GW; Walsh RA; Kranias EG
J Clin Invest; 1996 Jan; 97(2):533-9. PubMed ID: 8567978
[TBL] [Abstract][Full Text] [Related]
14. Co-ordinated changes in cAMP, phosphorylated phospholamban, Ca2+ and contraction following beta-adrenergic stimulation of rat heart.
Calaghan SC; White E; Colyer J
Pflugers Arch; 1998 Nov; 436(6):948-56. PubMed ID: 9799412
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms involved in the acidosis enhancement of the isoproterenol-induced phosphorylation of phospholamban in the intact heart.
Vittone L; Mundiña-Weilenmann C; Said M; Mattiazzi A
J Biol Chem; 1998 Apr; 273(16):9804-11. PubMed ID: 9545319
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylation of phospholamban at threonine-17 in the absence and presence of beta-adrenergic stimulation in neonatal rat cardiomyocytes.
Bartel S; Vetter D; Schlegel WP; Wallukat G; Krause EG; Karczewski P
J Mol Cell Cardiol; 2000 Dec; 32(12):2173-85. PubMed ID: 11112993
[TBL] [Abstract][Full Text] [Related]
17. Acidosis alters the phosphorylation of Ser16 and Thr17 of phospholamban in rat cardiac muscle.
Hulme JT; Colyer J; Orchard CH
Pflugers Arch; 1997 Aug; 434(4):475-83. PubMed ID: 9211815
[TBL] [Abstract][Full Text] [Related]
18. Phospholamban phosphorylation sites enhance the recovery of intracellular Ca2+ after perfusion arrest in isolated, perfused mouse heart.
Valverde CA; Mundiña-Weilenmann C; Reyes M; Kranias EG; Escobar AL; Mattiazzi A
Cardiovasc Res; 2006 May; 70(2):335-45. PubMed ID: 16516179
[TBL] [Abstract][Full Text] [Related]
19. Maximal inhibition of SERCA2 Ca(2+) affinity by phospholamban in transgenic hearts overexpressing a non-phosphorylatable form of phospholamban.
Brittsan AG; Carr AN; Schmidt AG; Kranias EG
J Biol Chem; 2000 Apr; 275(16):12129-35. PubMed ID: 10766848
[TBL] [Abstract][Full Text] [Related]
20. Translation of Ser16 and Thr17 phosphorylation of phospholamban into Ca 2+-pump stimulation.
Jackson WA; Colyer J
Biochem J; 1996 May; 316 ( Pt 1)(Pt 1):201-7. PubMed ID: 8645206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
